{"id":77994,"date":"2025-11-11T16:31:10","date_gmt":"2025-11-11T16:31:10","guid":{"rendered":"https:\/\/www.europesays.com\/se\/77994\/"},"modified":"2025-11-11T16:31:10","modified_gmt":"2025-11-11T16:31:10","slug":"novo-nordisk-sanker-priset-pa-wegovy-med-upp-till-33-procent-i-indien-reuters","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/77994\/","title":{"rendered":"Novo Nordisk s\u00e4nker priset p\u00e5 Wegovy med upp till 33 procent i Indien &#8211; Reuters"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Danska l\u00e4kemedelsbolaget Novo Nordisk har s\u00e4nkt priset p\u00e5 sitt viktminskningsl\u00e4kemedel Wegovy i Indien med upp till 33 procent, enligt dokument som Reuters tagit del av.\n <\/p>\n<p>Den h\u00f6gsta dosen p\u00e5 2,4 mg kostar nu 16 400 rupier, motsvarande cirka 187 dollar, j\u00e4mf\u00f6rt med tidigare 24 389 rupier. Den l\u00e4gsta dosen p\u00e5 0,25 mg priss\u00e4tts till 10 850 rupier fr\u00e5n tidigare 16 261.\n <\/p>\n<p>Priss\u00e4nkningen f\u00f6ljer efter att konkurrenten Eli Lillys Mounjaro nyligen blev Indiens mest s\u00e5lda l\u00e4kemedel m\u00e4tt i v\u00e4rde.<br \/>\n <br class=\"col-start-2\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Stefan Linn\u00e9r<br \/>\n <br class=\"col-start-2\"\/><br \/>\n stefan.linner@finwire.se<br \/>\n <br class=\"col-start-2\"\/><br \/>\n Nyhetsbyr\u00e5n Finwire<\/p>\n","protected":false},"excerpt":{"rendered":"Danska l\u00e4kemedelsbolaget Novo Nordisk har s\u00e4nkt priset p\u00e5 sitt viktminskningsl\u00e4kemedel Wegovy i Indien med upp till 33 procent,&hellip;\n","protected":false},"author":2,"featured_media":77249,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[22,23,26,27,17,21,24,25,28,29,15,16,18,34,31,33,32,30,19,20],"class_list":{"0":"post-77994","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-rubriker","8":"tag-breaking-news","9":"tag-breakingnews","10":"tag-featured-news","11":"tag-featurednews","12":"tag-headlines","13":"tag-huvudnyheter","14":"tag-latest-news","15":"tag-latestnews","16":"tag-main-news","17":"tag-mainnews","18":"tag-news","19":"tag-nyheter","20":"tag-rubriker","21":"tag-se","22":"tag-svenska","23":"tag-sverige","24":"tag-sweden","25":"tag-swedish","26":"tag-top-stories","27":"tag-topstories"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115532023927231042","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/77994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=77994"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/77994\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/77249"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=77994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=77994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=77994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}